Page last updated: 2024-08-24

adenosine and Amyotrophic Lateral Sclerosis

adenosine has been researched along with Amyotrophic Lateral Sclerosis in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	12 (75.00)	24.3611
2020's	4 (25.00)	2.80

Authors

Authors	Studies
Allen, SP; George, JG; Hall, B	1
Farinha-Ferreira, M; Rei, N; Ribeiro, JA; Sebastião, AM; Valente, CA; Vaz, SH	1
Costa Cruz, PH; Kawahara, Y	1
Okada, S; Sakurai, M; Yang, Y	1
Wood, H	1
Armida, M; Baqi, Y; Matteucci, A; Müller, CE; Pèzzola, A; Popoli, P; Potenza, RL	1
Aggarwal, T; Casci, I; Fackelmayer, FO; Lanson, NA; Maltare, A; Milioto, C; Monaghan, J; Pandey, UB; Pennuto, M; Scaramuzzino, C	1
Johnson, RA; Mitchell, GS; Nichols, NL; Satriotomo, I	1
Correia, AM; Gomes, R; Nascimento, F; Pousinha, PA; Ribeiro, JA; Sebastião, AM	1
Higashimori, H; Ng, SK; Tolman, M; Yang, Y	1
Nascimento, F; Ribeiro, JA; Sebastião, AM	1
Amadio, S; Apolloni, S; Parisi, C; Volonté, C	1
Fujii, S; Kitajo, K; Takanashi, K; Yamaguchi, A	1
Hogg, M; Keegan, LP; O'Connell, MA; Paro, S	1
Kwak, S	1
Barrick, CA; Becker, J; Buckley, H; Tessarollo, L; Yanpallewar, SU	1

Reviews

5 review(s) available for adenosine and Amyotrophic Lateral Sclerosis

Article	Year
Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders? Histology and histopathology, 2022, Volume: 37, Issue:3 Topics: Adenosine; Adenosine Deaminase; Amyotrophic Lateral Sclerosis; Brain; Humans; Neurodegenerative Diseases	2022
RNA Editing in Neurological and Neurodegenerative Disorders. Methods in molecular biology (Clifton, N.J.), 2021, Volume: 2181 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Epilepsy; Humans; Inosine; Nervous System Diseases; Neurodegenerative Diseases; Phenotype; RNA Editing	2021
Adenosine-to-inosine RNA editing in neurological development and disease. RNA biology, 2021, Volume: 18, Issue:7 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Astrocytoma; Bipolar Disorder; Central Nervous System Neoplasms; Epilepsy; Humans; Inosine; Kv1.1 Potassium Channel; MicroRNAs; Receptor, Serotonin, 5-HT2C; Receptors, AMPA; RNA Editing; Schizophrenia; Spasms, Infantile	2021
Purinergic contribution to amyotrophic lateral sclerosis. Neuropharmacology, 2016, Volume: 104 Topics: Adenosine; Adenosine Triphosphate; Amyotrophic Lateral Sclerosis; Animals; Astrocytes; Biomarkers; Brain; Humans; Microglia; Motor Neurons; Oligodendroglia; Receptors, Purinergic P1; Receptors, Purinergic P2; Schwann Cells; Signal Transduction	2016
RNA editing by mammalian ADARs. Advances in genetics, 2011, Volume: 73 Topics: Adenosine; Adenosine Deaminase; Alu Elements; Amyotrophic Lateral Sclerosis; Animals; Central Nervous System; Genetic Association Studies; Humans; Inosine; Male; Mammals; Mice; Mice, Transgenic; Neurons; Protein Binding; Rats; RNA Editing; RNA Interference; RNA-Binding Proteins; RNA, Double-Stranded	2011

Other Studies

11 other study(ies) available for adenosine and Amyotrophic Lateral Sclerosis

Article	Year
Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine. PloS one, 2022, Volume: 17, Issue:12 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Brain-Derived Neurotrophic Factor; Caffeine; Disease Models, Animal; Mice; Mice, Transgenic; Receptors, Purinergic P1; Spinal Cord; Superoxide Dismutase; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2022
Defects in adenosine metabolism identified in ALS. Nature reviews. Neurology, 2019, Volume: 15, Issue:3 Topics: Adenosine; Adenosine Deaminase; Amyotrophic Lateral Sclerosis; Astrocytes; Humans; Motor Neurons	2019
Modulating P1 Adenosine Receptors in Disease Progression of SOD1 Neurochemical research, 2019, Volume: 44, Issue:5 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Mice, Transgenic; Microglia; Motor Neurons; Phenethylamines; Receptors, Purinergic P1; Spinal Cord; Superoxide Dismutase-1	2019
Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo. PloS one, 2013, Volume: 8, Issue:4 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Arginine; Cytosol; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Enzyme Inhibitors; Gene Deletion; Gene Knockdown Techniques; HEK293 Cells; Humans; Inclusion Bodies; Membrane Proteins; Methylation; Methyltransferases; Mutant Proteins; Mutation; Protein Binding; Protein Transport; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA-Binding Protein FUS; Subcellular Fractions	2013
Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats. Respiratory physiology & neurobiology, 2014, Jun-15, Volume: 197 Topics: Acetophenones; Adenosine; Adenosine A2 Receptor Antagonists; Amyotrophic Lateral Sclerosis; Animals; Enzyme Inhibitors; Humans; Male; Methysergide; Motor Neurons; NADPH Oxidases; Phrenic Nerve; Plethysmography; Pulmonary Ventilation; Rats, Sprague-Dawley; Rats, Transgenic; Respiration; Serotonin; Serotonin Antagonists; Superoxide Dismutase; Superoxide Dismutase-1; Tidal Volume; Xanthines	2014
Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase. PloS one, 2014, Volume: 9, Issue:8 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Excitatory Postsynaptic Potentials; Humans; Male; Mice, Transgenic; Motor Endplate; Mutation; Neuromuscular Junction; Phenethylamines; Receptor, Adenosine A2A; Superoxide Dismutase; Synaptic Transmission	2014
Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis. Experimental neurology, 2015, Volume: 267 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Animals; Astrocytes; Cell Differentiation; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Female; Humans; Male; Mediator Complex; Mice; Mice, Transgenic; Middle Aged; Motor Neurons; Muscle Strength; Purines; Receptor, Adenosine A2A; Signal Transduction; Spinal Cord; Superoxide Dismutase	2015
Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission. Purinergic signalling, 2015, Volume: 11, Issue:4 Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Amyotrophic Lateral Sclerosis; Animals; Evoked Potentials; Mice; Motor Endplate; Neuromuscular Junction; Phenethylamines; Receptor Cross-Talk; Receptor, Adenosine A1; Receptor, Adenosine A2A; Superoxide Dismutase; Superoxide Dismutase-1; Synaptic Transmission; Xanthines	2015
Treatment with a Global Methyltransferase Inhibitor Induces the Intranuclear Aggregation of ALS-Linked FUS Mutant In Vitro. Neurochemical research, 2016, Volume: 41, Issue:4 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Cell Line, Tumor; Cell Nucleus; HEK293 Cells; Humans; Methylation; Methyltransferases; Mutation; Protein Aggregates; RNA-Binding Protein FUS; Subcellular Fractions; Time Factors	2016
[Inefficient A-to-I RNA editing and ALS]. Rinsho shinkeigaku = Clinical neurology, 2010, Volume: 50, Issue:11 Topics: Adenosine; Adenosine Deaminase; Amyotrophic Lateral Sclerosis; Animals; Calcium; Catalysis; Humans; Inosine; Mice; Molecular Targeted Therapy; Motor Neurons; Receptors, AMPA; RNA Editing; RNA-Binding Proteins	2010
Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PloS one, 2012, Volume: 7, Issue:6 Topics: Adenosine; Adenosine A2 Receptor Agonists; Amyotrophic Lateral Sclerosis; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Disease Progression; Mice; Phenethylamines; Receptor, trkB; Superoxide Dismutase	2012